Genomics In Cancer Care Market - Global Outlook and Forecast 2021-2027

Genomics In Cancer Care Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Genomics In Cancer Care Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genomics In Cancer Care Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genomics In Cancer Care Overall Market Size
2.1 Global Genomics In Cancer Care Market Size: 2021 VS 2027
2.2 Global Genomics In Cancer Care Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genomics In Cancer Care Players in Global Market
3.2 Top Global Genomics In Cancer Care Companies Ranked by Revenue
3.3 Global Genomics In Cancer Care Revenue by Companies
3.4 Top 3 and Top 5 Genomics In Cancer Care Companies in Global Market, by Revenue in 2020
3.5 Global Companies Genomics In Cancer Care Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genomics In Cancer Care Players in Global Market
3.6.1 List of Global Tier 1 Genomics In Cancer Care Companies
3.6.2 List of Global Tier 2 and Tier 3 Genomics In Cancer Care Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Genomics In Cancer Care Market Size Markets, 2021 & 2027
4.1.2 Instruments
4.1.3 Consumables
4.1.4 Services
4.2 By Type - Global Genomics In Cancer Care Revenue & Forecasts
4.2.1 By Type - Global Genomics In Cancer Care Revenue, 2016-2021
4.2.2 By Type - Global Genomics In Cancer Care Revenue, 2022-2027
4.2.3 By Type - Global Genomics In Cancer Care Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genomics In Cancer Care Market Size, 2021 & 2027
5.1.2 Diagnostics
5.1.3 Personalized Medicine
5.1.4 Drug Discovery
5.1.5 Development
5.1.6 Research
5.2 By Application - Global Genomics In Cancer Care Revenue & Forecasts
5.2.1 By Application - Global Genomics In Cancer Care Revenue, 2016-2021
5.2.2 By Application - Global Genomics In Cancer Care Revenue, 2022-2027
5.2.3 By Application - Global Genomics In Cancer Care Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Genomics In Cancer Care Market Size, 2021 & 2027
6.2 By Region - Global Genomics In Cancer Care Revenue & Forecasts
6.2.1 By Region - Global Genomics In Cancer Care Revenue, 2016-2021
6.2.2 By Region - Global Genomics In Cancer Care Revenue, 2022-2027
6.2.3 By Region - Global Genomics In Cancer Care Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Genomics In Cancer Care Revenue, 2016-2027
6.3.2 US Genomics In Cancer Care Market Size, 2016-2027
6.3.3 Canada Genomics In Cancer Care Market Size, 2016-2027
6.3.4 Mexico Genomics In Cancer Care Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Genomics In Cancer Care Revenue, 2016-2027
6.4.2 Germany Genomics In Cancer Care Market Size, 2016-2027
6.4.3 France Genomics In Cancer Care Market Size, 2016-2027
6.4.4 U.K. Genomics In Cancer Care Market Size, 2016-2027
6.4.5 Italy Genomics In Cancer Care Market Size, 2016-2027
6.4.6 Russia Genomics In Cancer Care Market Size, 2016-2027
6.4.7 Nordic Countries Genomics In Cancer Care Market Size, 2016-2027
6.4.8 Benelux Genomics In Cancer Care Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Genomics In Cancer Care Revenue, 2016-2027
6.5.2 China Genomics In Cancer Care Market Size, 2016-2027
6.5.3 Japan Genomics In Cancer Care Market Size, 2016-2027
6.5.4 South Korea Genomics In Cancer Care Market Size, 2016-2027
6.5.5 Southeast Asia Genomics In Cancer Care Market Size, 2016-2027
6.5.6 India Genomics In Cancer Care Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Genomics In Cancer Care Revenue, 2016-2027
6.6.2 Brazil Genomics In Cancer Care Market Size, 2016-2027
6.6.3 Argentina Genomics In Cancer Care Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genomics In Cancer Care Revenue, 2016-2027
6.7.2 Turkey Genomics In Cancer Care Market Size, 2016-2027
6.7.3 Israel Genomics In Cancer Care Market Size, 2016-2027
6.7.4 Saudi Arabia Genomics In Cancer Care Market Size, 2016-2027
6.7.5 UAE Genomics In Cancer Care Market Size, 2016-2027
7 Players Profiles
7.1 Illumina
7.1.1 Illumina Corporate Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Genomics In Cancer Care Major Product Offerings
7.1.4 Illumina Genomics In Cancer Care Revenue in Global (2016-2021)
7.1.5 Illumina Key News
7.2 Thermo Fisher scientific
7.2.1 Thermo Fisher scientific Corporate Summary
7.2.2 Thermo Fisher scientific Business Overview
7.2.3 Thermo Fisher scientific Genomics In Cancer Care Major Product Offerings
7.2.4 Thermo Fisher scientific Genomics In Cancer Care Revenue in Global (2016-2021)
7.2.5 Thermo Fisher scientific Key News
7.3 Agilent
7.3.1 Agilent Corporate Summary
7.3.2 Agilent Business Overview
7.3.3 Agilent Genomics In Cancer Care Major Product Offerings
7.3.4 Agilent Genomics In Cancer Care Revenue in Global (2016-2021)
7.3.5 Agilent Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Genomics In Cancer Care Major Product Offerings
7.4.4 Roche Genomics In Cancer Care Revenue in Global (2016-2021)
7.4.5 Roche Key News
7.5 Cancer Genetics
7.5.1 Cancer Genetics Corporate Summary
7.5.2 Cancer Genetics Business Overview
7.5.3 Cancer Genetics Genomics In Cancer Care Major Product Offerings
7.5.4 Cancer Genetics Genomics In Cancer Care Revenue in Global (2016-2021)
7.5.5 Cancer Genetics Key News
7.6 Beckman Coulter
7.6.1 Beckman Coulter Corporate Summary
7.6.2 Beckman Coulter Business Overview
7.6.3 Beckman Coulter Genomics In Cancer Care Major Product Offerings
7.6.4 Beckman Coulter Genomics In Cancer Care Revenue in Global (2016-2021)
7.6.5 Beckman Coulter Key News
7.7 Bio-Rad
7.7.1 Bio-Rad Corporate Summary
7.7.2 Bio-Rad Business Overview
7.7.3 Bio-Rad Genomics In Cancer Care Major Product Offerings
7.4.4 Bio-Rad Genomics In Cancer Care Revenue in Global (2016-2021)
7.7.5 Bio-Rad Key News
7.8 Danaher
7.8.1 Danaher Corporate Summary
7.8.2 Danaher Business Overview
7.8.3 Danaher Genomics In Cancer Care Major Product Offerings
7.8.4 Danaher Genomics In Cancer Care Revenue in Global (2016-2021)
7.8.5 Danaher Key News
7.9 Sigma Aldrich
7.9.1 Sigma Aldrich Corporate Summary
7.9.2 Sigma Aldrich Business Overview
7.9.3 Sigma Aldrich Genomics In Cancer Care Major Product Offerings
7.9.4 Sigma Aldrich Genomics In Cancer Care Revenue in Global (2016-2021)
7.9.5 Sigma Aldrich Key News
7.10 Pacific Biosciences
7.10.1 Pacific Biosciences Corporate Summary
7.10.2 Pacific Biosciences Business Overview
7.10.3 Pacific Biosciences Genomics In Cancer Care Major Product Offerings
7.10.4 Pacific Biosciences Genomics In Cancer Care Revenue in Global (2016-2021)
7.10.5 Pacific Biosciences Key News
7.11 Quest Diagnostics
7.11.1 Quest Diagnostics Corporate Summary
7.11.2 Quest Diagnostics Business Overview
7.11.3 Quest Diagnostics Genomics In Cancer Care Major Product Offerings
7.11.4 Quest Diagnostics Genomics In Cancer Care Revenue in Global (2016-2021)
7.11.5 Quest Diagnostics Key News
7.12 Luminex
7.12.1 Luminex Corporate Summary
7.12.2 Luminex Business Overview
7.12.3 Luminex Genomics In Cancer Care Major Product Offerings
7.12.4 Luminex Genomics In Cancer Care Revenue in Global (2016-2021)
7.12.5 Luminex Key News
7.13 Oxford Gene Technology
7.13.1 Oxford Gene Technology Corporate Summary
7.13.2 Oxford Gene Technology Business Overview
7.13.3 Oxford Gene Technology Genomics In Cancer Care Major Product Offerings
7.13.4 Oxford Gene Technology Genomics In Cancer Care Revenue in Global (2016-2021)
7.13.5 Oxford Gene Technology Key News
7.14 PerkinElmer
7.14.1 PerkinElmer Corporate Summary
7.14.2 PerkinElmer Business Overview
7.14.3 PerkinElmer Genomics In Cancer Care Major Product Offerings
7.14.4 PerkinElmer Genomics In Cancer Care Revenue in Global (2016-2021)
7.14.5 PerkinElmer Key News
7.15 Qiagen
7.15.1 Qiagen Corporate Summary
7.15.2 Qiagen Business Overview
7.15.3 Qiagen Genomics In Cancer Care Major Product Offerings
7.15.4 Qiagen Genomics In Cancer Care Revenue in Global (2016-2021)
7.15.5 Qiagen Key News
7.16 GE Healthcare
7.16.1 GE Healthcare Corporate Summary
7.16.2 GE Healthcare Business Overview
7.16.3 GE Healthcare Genomics In Cancer Care Major Product Offerings
7.16.4 GE Healthcare Genomics In Cancer Care Revenue in Global (2016-2021)
7.16.5 GE Healthcare Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Genomics In Cancer Care Market Opportunities & Trends in Global Market
Table 2. Genomics In Cancer Care Market Drivers in Global Market
Table 3. Genomics In Cancer Care Market Restraints in Global Market
Table 4. Key Players of Genomics In Cancer Care in Global Market
Table 5. Top Genomics In Cancer Care Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Genomics In Cancer Care Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Genomics In Cancer Care Revenue Share by Companies, 2016-2021
Table 8. Global Companies Genomics In Cancer Care Product Type
Table 9. List of Global Tier 1 Genomics In Cancer Care Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genomics In Cancer Care Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Genomics In Cancer Care Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Genomics In Cancer Care Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Genomics In Cancer Care Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Genomics In Cancer Care Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Genomics In Cancer Care Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Genomics In Cancer Care Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Genomics In Cancer Care Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Genomics In Cancer Care Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Genomics In Cancer Care Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Genomics In Cancer Care Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Genomics In Cancer Care Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Genomics In Cancer Care Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Genomics In Cancer Care Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Genomics In Cancer Care Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Genomics In Cancer Care Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Genomics In Cancer Care Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Genomics In Cancer Care Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Genomics In Cancer Care Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Genomics In Cancer Care Revenue, (US$, Mn), 2022-2027
Table 30. Illumina Corporate Summary
Table 31. Illumina Genomics In Cancer Care Product Offerings
Table 32. Illumina Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 33. Thermo Fisher scientific Corporate Summary
Table 34. Thermo Fisher scientific Genomics In Cancer Care Product Offerings
Table 35. Thermo Fisher scientific Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 36. Agilent Corporate Summary
Table 37. Agilent Genomics In Cancer Care Product Offerings
Table 38. Agilent Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 39. Roche Corporate Summary
Table 40. Roche Genomics In Cancer Care Product Offerings
Table 41. Roche Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 42. Cancer Genetics Corporate Summary
Table 43. Cancer Genetics Genomics In Cancer Care Product Offerings
Table 44. Cancer Genetics Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 45. Beckman Coulter Corporate Summary
Table 46. Beckman Coulter Genomics In Cancer Care Product Offerings
Table 47. Beckman Coulter Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 48. Bio-Rad Corporate Summary
Table 49. Bio-Rad Genomics In Cancer Care Product Offerings
Table 50. Bio-Rad Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 51. Danaher Corporate Summary
Table 52. Danaher Genomics In Cancer Care Product Offerings
Table 53. Danaher Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 54. Sigma Aldrich Corporate Summary
Table 55. Sigma Aldrich Genomics In Cancer Care Product Offerings
Table 56. Sigma Aldrich Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 57. Pacific Biosciences Corporate Summary
Table 58. Pacific Biosciences Genomics In Cancer Care Product Offerings
Table 59. Pacific Biosciences Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 60. Quest Diagnostics Corporate Summary
Table 61. Quest Diagnostics Genomics In Cancer Care Product Offerings
Table 62. Quest Diagnostics Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 63. Luminex Corporate Summary
Table 64. Luminex Genomics In Cancer Care Product Offerings
Table 65. Luminex Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 66. Oxford Gene Technology Corporate Summary
Table 67. Oxford Gene Technology Genomics In Cancer Care Product Offerings
Table 68. Oxford Gene Technology Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 69. PerkinElmer Corporate Summary
Table 70. PerkinElmer Genomics In Cancer Care Product Offerings
Table 71. PerkinElmer Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 72. Qiagen Corporate Summary
Table 73. Qiagen Genomics In Cancer Care Product Offerings
Table 74. Qiagen Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
Table 75. GE Healthcare Corporate Summary
Table 76. GE Healthcare Genomics In Cancer Care Product Offerings
Table 77. GE Healthcare Genomics In Cancer Care Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Genomics In Cancer Care Segment by Type
Figure 2. Genomics In Cancer Care Segment by Application
Figure 3. Global Genomics In Cancer Care Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Genomics In Cancer Care Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Genomics In Cancer Care Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2020
Figure 8. By Type - Global Genomics In Cancer Care Revenue Market Share, 2016-2027
Figure 9. By Application - Global Genomics In Cancer Care Revenue Market Share, 2016-2027
Figure 10. By Region - Global Genomics In Cancer Care Revenue Market Share, 2016-2027
Figure 11. By Country - North America Genomics In Cancer Care Revenue Market Share, 2016-2027
Figure 12. US Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Genomics In Cancer Care Revenue Market Share, 2016-2027
Figure 16. Germany Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 17. France Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Genomics In Cancer Care Revenue Market Share, 2016-2027
Figure 24. China Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 28. India Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Genomics In Cancer Care Revenue Market Share, 2016-2027
Figure 30. Brazil Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Genomics In Cancer Care Revenue Market Share, 2016-2027
Figure 33. Turkey Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Genomics In Cancer Care Revenue, (US$, Mn), 2016-2027
Figure 37. Illumina Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Thermo Fisher scientific Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Agilent Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Roche Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Cancer Genetics Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Beckman Coulter Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Bio-Rad Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Danaher Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sigma Aldrich Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Pacific Biosciences Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Quest Diagnostics Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Luminex Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Oxford Gene Technology Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. PerkinElmer Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Qiagen Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. GE Healthcare Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Agrigenomics Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 87

Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other technology. The global Agrigenomics market was valued at US$ 4849.2 million in 2023 and is anticipated to reach US$ 7524.5 million by 2030, witnessing a CAGR of 6.4% during The forecast period 2024-2030. Thermo Fisher Scientific,......

Global Agrigenomics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108

According to our LPI (LP Information) latest study, the global Agrigenomics market size was valued at US$ 4743.7 million in 2023. With growing demand in downstream market, the Agrigenomics is forecast to a readjusted size of US$ 7439.4 million by 2030 with a CAGR of 6.6% during review period. The research report highlights the growth potential of the global Agrigenomics market. Agrigenomics are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Agrigenomics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Agrigenomics market size was valued at USD 4989.6 million in 2023 and is forecast to a readjusted size of USD 7564.5 million by 2030 with a CAGR of 6.1% during review period. Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other t......

Global Gene Editing Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 97

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Editing market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Merck - Horizo??n Discovery - Sangamo BioSciences - Integrated DNA Technologies - Lonza - New England Biolabs - ......

Global Agrigenomics Professional Survey Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 101

Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......

Global Agrigenomics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Nov-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Agrigenomics market: According to our latest research, the global Agrigenomics market looks promising in the next 5 years. As of 2022, the global Agrigenomics market was estimated at USD 5139.47 million, and it's anticipated to reach USD 7676.54 million in 2028, with a CAGR of 6.92% during the forecast years. Agrigenomics is defined as the study of the genetic makeup of crops and livestock and how genes influence the produce. Application of genomics ......

Global Agrigenomics Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166

Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......

Global Genomics in Cancer Care Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Nov-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Genomics in Cancer Care market: According to our latest research, the global Genomics in Cancer Care market looks promising in the next 5 years. As of 2022, the global Genomics in Cancer Care market was estimated at USD 4369.0 million, and it's anticipated to reach USD 11429.15 million in 2028, with a CAGR of 17.38% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......

Gene Editing Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 200

Gene Editing Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene editing deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of gene editing deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter gene editing deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs